Commission establishes portfolio of 10 most promising treatments for COVID-19

22/10/2021 26 Views
Commission establishes portfolio of 10 most promising treatments for COVID-19

Delivering on a key action from the EU Strategy on COVID-19 Therapeutics, on October 22, the Commission established a portfolio of 10 potential COVID-19 therapeutics. The list established is based on independent scientific advice, and focuses on COVID-19 treatment candidates that are likely to be authorised and therefore available on the European market soon. These therapeutics will bring treatment to patients across the EU as fast as possible provided that their safety and effectiveness has been confirmed by the European Medicines Agency.

While vaccination offers the best way to end the pandemic and get back to normal life, in parallel, the Commission is ensuring that the COVID-19 therapeutics are available to treat those who are infected.

The EU Strategy on COVID-19 Therapeutics is an integral element of the work to build a strong European Health Union, and is modelled on the successful EU Vaccines Strategy.

Related articles